About Joshua A. Feiger

Josh Feiger advises companies and individuals buying, selling and investing in businesses. Josh focuses on structuring, negotiating and managing mergers, acquisitions, dispositions, equity financings, and other complex transactions.

A business-minded approach

Josh has vast experience representing private equity funds, family offices, independent sponsors, founder-owned businesses and public companies through mergers, acquisitions, dispositions, equity financings, other complex transactions, and regarding general corporate matters. Josh has represented clients across a variety of industries, including manufacturing, industrials, business services, health care, financial services, food and beverage, technology and real estate. His transactions have ranged in size from several million dollars to more than five billion dollars. Josh takes a business-minded approach to his practice, serving as a valuable advisor and focusing on specific client needs for each situation.

Josh began his career in the Chicago office of an international law firm.

⇣   Expand to read more

Practice Focus

  • Merger and acquisitions
  • Dispositions
  • Private equity
  • Joint ventures
  • General corporate matters

Representative Experience

  • Represented a digital services management and consulting firm in the sale of a controlling interest in its business for approximately $2.3 billion, and in connection with multiple acquisitions with transaction values in excess of $80 million, in the aggregate.
  • Represented a family office private equity sponsor in the acquisition of a stormwater solutions business for approximately $280 million.
  • Represented a privately held liquor company in its sale to a wine and liquor business for approximately $220 million.
  • Represented a private equity-owned information technology company in the acquisition of an information technology support services business for approximately $155 million.
  • Represented a private equity-owned, service-based systems integrator in multiple acquisitions in the United States and abroad with transaction values in excess of $150 million, in the aggregate.
  • Represented a publicly traded company in its acquisition of a private college system for approximately $135 million.
  • Represented a family office private equity sponsor in the acquisition of an industrial equipment rental and sales business for approximately $125 million.
  • Represented a private equity sponsor in the sale of a laboratory services business to a publicly traded company for approximately $110 million, and multiple acquisitions by such business prior to such sale.
  • Represented a private equity sponsor in the acquisition of a warehousing, distribution and logistics business for approximately $95 million.
  • Represented a private equity sponsor in its minority investment in a transportation solutions company for approximately $90 million.
  • Represented a venture capital-backed manufacturer and seller of fitness equipment in its sale to a private equity sponsor for approximately $85 million.
  • Represented a private equity sponsor in the sale of a construction finishings provider for approximately $70 million.
  • Represented a private equity sponsor in the acquisition of a security products business for approximately $45 million.
  • Represented a private equity sponsor in a take-private acquisition of a publicly traded biotechnology business.
  • Represented an independent sponsor in the acquisition of a transportation services and brokerage provider.
  • Represented an independent sponsor in the acquisition of a power tool accessories and hand tool business.
  • Represented a privately held business in the sale of a renewable energy waste and recycling business.
  • Represented a publicly traded packaged meat and frozen food manufacturer in its sale to a publicly traded strategic acquiror for approximately $8.55 billion. *
  • Represented a publicly traded business development company in its sale to a publicly traded acquiror for approximately $3.43 billion. *
  • Represented a publicly traded medical technologies company in its approximately $1.28 billion acquisition of a private equity-owned portfolio company. *
  • Represented a publicly traded biotechnology company in two acquisitions of privately owned, early-stage biopharmaceutical companies with transaction values in excess of $325 million, in the aggregate. *
  • Represented a publicly traded foodservice equipment manufacturer in acquisitions of over 10 domestic, foreign and multinational private companies and divisions of private and public companies. *
  • Represented a publicly traded health care company in its negotiations with an activist investor. *
  • Represented a Brazilian aerospace conglomerate in a strategic joint venture. *
* Experience prior to Katten

Presentations and Events